T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
BioMarin Pharmaceuticals
BMRN
$13.5B
| $274M | 0.06% |
3,525,314
-2,693,446
| -43% | -$229M |
|
327
IBM
IBM
$225B
| $273M | 0.06% |
1,878,928
-677,297
| -26% | -$97M |
|
328
Corpay
CPAY
$26.7B
| $271M | 0.06% |
1,890,191
+185,047
| +11% | +$27.5M |
|
|
XLNX
329
DELISTED
Xilinx Inc
XLNX
| $270M | 0.06% |
5,862,702
-25,714
| -0.4% | -$1.18M |
|
330
DexCom
DXCM
$33.8B
| $270M | 0.06% |
13,605,116
-3,415,840
| -20% | -$58.2M |
|
331
Aramark
ARMK
$15.9B
| $269M | 0.06% |
11,160,592
+57,317
| +0.5% | +$1.38M |
|
|
MSCC
332
DELISTED
Microsemi Corp
MSCC
| $269M | 0.06% |
8,220,088
+2,686,052
| +49% | +$91.9M |
|
|
BHI
333
DELISTED
Baker Hughes
BHI
| $266M | 0.06% |
5,898,450
+1,563,977
| +36% | +$70.8M |
|
334
Devon Energy
DVN
$49.9B
| $265M | 0.06% |
7,299,402
-432,020
| -6% | -$14.7M |
|
335
Southwest Airlines
LUV
$22.3B
| $264M | 0.06% |
6,736,285
-1,552,605
| -19% | -$66.5M |
|
336
Ingredion
INGR
$6.6B
| $264M | 0.06% |
2,040,490
-2,031,904
| -50% | -$236M |
|
337
Cable One
CABO
$192M
| $263M | 0.06% |
514,662
+112,781
| +28% | +$53.9M |
|
|
TRCO
338
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $262M | 0.06% |
6,694,350
+344,692
| +5% | +$13.4M |
|
|
BKI
339
DELISTED
Black Knight, Inc. Common Stock
BKI
| $262M | 0.06% |
6,970,613
+387,614
| +6% | +$12.8M |
|
340
TC Energy
TRP
$66.3B
| $261M | 0.06% |
5,774,980
+5,752,980
| +26,150% | +$237M |
|
|
MINI
341
DELISTED
Mobile Mini Inc
MINI
| $260M | 0.06% |
7,513,456
-148,870
| -2% | -$4.98M |
|
|
HR
342
DELISTED
Healthcare Realty Trust Incorporated
HR
| $260M | 0.06% |
7,436,169
+31,796
| +0.4% | +$1.01M |
|
|
DGI
343
DELISTED
DigitalGlobe Inc.
DGI
| $259M | 0.05% |
12,085,171
-30,539
| -0.3% | -$615K |
|
344
Akamai
AKAM
$16.8B
| $258M | 0.05% |
4,613,235
-2,183,323
| -32% | -$115M |
|
345
Colgate-Palmolive
CL
$73.6B
| $257M | 0.05% |
3,507,139
-23,082
| -0.7% | -$1.64M |
|
|
TWX
346
DELISTED
Time Warner Inc
TWX
| $257M | 0.05% |
3,490,640
+615,682
| +21% | +$45.5M |
|
347
White Mountains Insurance
WTM
$5.04B
| $256M | 0.05% |
303,758
-27,232
| -8% | -$22.2M |
|
348
CF Industries
CF
$17.8B
| $255M | 0.05% |
10,599,649
+774,180
| +8% | +$23M |
|
|
CPGX
349
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
| $254M | 0.05% |
9,950,497
-2,007,862
| -17% | -$51.2M |
|
350
Sysco
SYY
$40.3B
| $252M | 0.05% |
4,962,618
-3,910,553
| -44% | -$189M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.